Antimicrobial resistance is a major public health problem globally. Likewise, forms of
tuberculosis (TB) resistant to first-and second-line TB medicines present a major challenge …

Aminoglycosides are natural or semisynthetic antibiotics derived from actinomycetes. They
were among the first antibiotics to be introduced for routine clinical use and several …

Objective: To compare the effectiveness of second line injectables containing shorter
(duration 9–12 months) and longer treatment regimens (LTR, duration≥ 20 months) among …

耐药结核病, 尤其耐多药结核病, 是当今结核病防治工作中遇到的重大挑战.
为了使耐药结核的化学治疗工作规范化, 中国防痨协会于2002 年编写发行了 …

Background: The American Thoracic Society, US Centers for Disease Control and
Prevention, European Respiratory Society, and Infectious Diseases Society of America …

Drug-resistant tuberculosis (TB) remains a major challenge to global health and to
healthcare in the UK. In 2014, a total of 6,520 cases of TB were recorded in England, of …

The continuing spread of drug-resistant tuberculosis (TB) is one of the most urgent and
difficult challenges facing global TB control. Patients who are infected with strains resistant …

Extrapulmonary tuberculosis (EPTB) constitutes about 20% of all cases of tuberculosis (TB)
in Korea. Diagnosing EPTB remains challenging because clinical samples obtained from …

This paper describes an action framework for countries with low tuberculosis (TB) incidence
(< 100 TB cases per million population) that are striving for TB elimination. The framework …

The first edition of Guidance for national tuberculosis programmes on the management of
tuberculosis in children was published in 2006. It resulted in the revision or development of …